Top Markets
Coin of the day
IDL Diagnostics AB (publ) IDL Diagnostics AB (publ)

IDL Diagnostics AB (publ)

IDLDX
株式のランク #32452
Specializing in in vitro diagnostics (IVD), IDL Diagnostics AB (publ) develops... Specializing in in vitro diagnostics (IVD), IDL Diagnostics AB (publ) develops and markets diagnostic tests aimed at detecting cancer and bacterial infections within the Swedish market. Its product portfolio includes UBC Rapid, a point-of-care solution for both diagnosing and tracking bladder cancer; AroCell TK 210 ELISA, utilized as a biomarker for identifying tumor cells; and TUBEX TF, an in vitro diagnostic tool for pinpointing acute typhoid fever. Formerly operating as AroCell AB (publ), the company is scheduled to adopt the name IDL Diagnostics AB (publ) in May 2025. Established in 2000, its operations are headquartered in Stockholm, Sweden.
株価
$0.04367217
最終同期: 2026-08-17
時価総額
$10.06M
変化(1日)
3.99%
変化(1年)
-26.77%
SE
取引 IDL Diagnostics AB (publ) (IDLDX)

カテゴリー

IDL Diagnostics AB (publ)(IDLDX)の配当利回りの履歴
IDL Diagnostics AB (publ)(銘柄コード: IDLDX)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
IDL Diagnostics AB (publ)(IDLDX)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)